0000950170-23-032731.txt : 20230712 0000950170-23-032731.hdr.sgml : 20230712 20230712211625 ACCESSION NUMBER: 0000950170-23-032731 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230201 FILED AS OF DATE: 20230712 DATE AS OF CHANGE: 20230712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lucchino David L. CENTRAL INDEX KEY: 0001785288 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 231085620 MAIL ADDRESS: STREET 1: C/O FREQUENCY THERAPEUTICS, INC. STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 4/A 1 ownership.xml 4/A X0407 4/A 2023-02-01 2023-07-07 0001703647 Frequency Therapeutics, Inc. FREQ 0001785288 Lucchino David L. C/O FREQUENCY THERAPEUTICS, INC. 75 HAYDEN AVE, SUITE 300 LEXINGTON MA 02421 true true false false President and CEO true Common Stock 2023-02-01 5 G false 13345 0.00 D 456766 D Common Stock 2023-02-03 5 G false 33345 0.00 D 423421 D Common Stock 2023-07-04 4 M false 300000 A 723421 D Common Stock 2023-07-06 4 S false 2773 0.34 D 720648 D Restricted Stock Units 2023-07-04 4 M false 300000 D Common Stock 300000 0 D Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock. Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.33 to $0.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. The Restricted Stock Units vested on July 4, 2023 and do not have an expiration date. This Form 4/A is being filed to correct (i) the vesting transaction dates, (ii) the number of Restricted Stock Units reported as vesting on Table II in columns 5 and 7, (iii) the aggregate derivatives following the transaction on Table II in column 9, (iv) the acquisition of shares on Table I in column 4, and (v) the aggregate securities following the transaction in column 5 of Table I. /s/ James P. Abely, Attorney-in-Fact for David L. Lucchino 2023-07-12